AntiInfectiveMeds
Since 2010
| Quantity | Price per tablet | You save | Total price | |
|---|---|---|---|---|
| 30 | $4.73 | - | $142.00 | |
| 60 | $4.38 | $21.00 | $263.00 | |
| 90 | $4.19 | $49.00 | $377.00 |
Your order is carefully packed and ships within 24 hours. Here is what a typical package looks like.
Sized like a regular personal letter (9.4x4.3x0.3 inches), with no indication of what is inside.
| Shipping Method | Estimated delivery |
|---|---|
| Express Free for orders over $300.00 | Estimated delivery to the U.S.: 4-7 days |
| Standard Free for orders over $200.00 | Estimated delivery to the U.S.: 14-21 days |
| Country | Brand Names |
|---|---|
| United States | Viread |
WHO estimates that about 254 million people were living with chronic hepatitis B (CHB) in 2022. Chronic HBV infection can lead to long-term complications such as cirrhosis, liver failure, and an increased risk of hepatocellular carcinoma (HCC). Over the last decade, HBV management has improved, and effective antiviral therapy options include tenofovir disoproxil fumarate (TDF).
TDF is an orally administered pro-drug of tenofovir, a nucleotide reverse transcriptase inhibitor active against both hepatitis B virus (HBV) and HIV-1. For HIV-1, TDF is used only in combination with other antiretroviral agents. For chronic hepatitis B, TDF is used as an antiviral therapy option; patients should be tested for HIV-1 before starting TDF for HBV.
Clinical trial data support that TDF can help suppress HBV DNA in many patients during long-term therapy. In adult trials, continued follow-up included long-term treatment up to 384 weeks in extension phases. In the treatment of chronic hepatitis B, the optimal duration of treatment is unknown.
Important safety note: severe acute exacerbations of hepatitis B have been reported after discontinuation of anti-hepatitis B therapy, including TDF. Hepatic function should be monitored with clinical and laboratory follow-up for at least several months after stopping therapy; if appropriate, resumption of treatment may be warranted.
VIREAD (tenofovir disoproxil fumarate, TDF) is indicated for the treatment of chronic hepatitis B virus (HBV) in adults and pediatric patients 2 years of age and older weighing at least 10 kg.
TDF is primarily eliminated by the kidneys. Coadministration with drugs that are eliminated by active tubular secretion may increase concentrations of tenofovir and/or the coadministered drug; drugs that decrease renal function may increase tenofovir concentrations. In the treatment of chronic hepatitis B, TDF should not be administered in combination with adefovir dipivoxil.
Along with its desired action, this medicine may cause unwanted effects. Evaluation of adverse reactions in CHB with compensated liver disease is based on controlled clinical trials in 641 subjects who received treatment during a 48-week double-blind period.
In these trials, the most common adverse reaction (all grades) was nausea (9%). Other treatment-emergent adverse reactions reported in more than 5% of subjects included abdominal pain, diarrhea, headache, dizziness, fatigue, nasopharyngitis, back pain, and skin rash.
It should be noted that stopping therapy can lead to a flare (worsening) of hepatitis B. During follow-up after discontinuation, monitor liver function with clinical and laboratory parameters for at least several months. If appropriate, it may be advisable to resume treatment.
Store TDF tablets at 77°F (25°C); excursions permitted to 59-86°F (15-30°C) (USP Controlled Room Temperature). Keep the bottle tightly closed and dispense only in the original container. Do not use if the seal over the bottle opening is broken or missing. Keep out of reach of children.
I found what appears to be the same tenofovir product at another online store for about half the price. Why should I order from you instead?
We stand behind the quality of the products we offer. We cannot verify what another seller supplies, how it is sourced or handled, or whether a similarly named, lower-priced offer is truly equivalent in manufacturer, origin, and product quality. The choice is yours, but only you can decide whether the savings are worth accepting that uncertainty.
I take tenofovir disoproxil for chronic hepatitis B and just found out that I am pregnant. Is it safe to keep taking it?
Tenofovir disoproxil is an established treatment option during pregnancy, and available human data have not shown an increased overall risk of major birth defects. Contact the clinician managing your hepatitis B promptly to review your treatment, but do not stop it on your own because stopping antiviral therapy can lead to a hepatitis B flare.
| Active ingredient | Tenofovir disoproxil |
|---|---|
| Drug class | Nucleotide reverse transcriptase inhibitor (NtRTI) |
| Dosage form | Tablet |
| Available strengths | 300 mg |
| Route | Oral |
| Storage | Store below 86°F in a dry place, protected from moisture, in the original container. |
| ATC code | J05AF07 |
This product has 7 ratings, but only 6 written reviews so far. Share your experience and help other customers.
Fast dispatch.
Good quality overall.
I received the order for tenofovir disoproxil in a plain outer package that did not reveal the contents.
The Tenvir order arrived fine.
Easy to place the order.
No problems at all.
